ASIA-PACIFIC BOTULINUM TOXIN MARKET 2021-2028

Lifesciences | Healthcare & Wellness

ASIA-PACIFIC BOTULINUM TOXIN MARKET 2021-2028

Market by Type, Application, End-user, and Country Outlook | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton Market Research envisions the botulinum toxin market in the Asia-Pacific to witness growth, with a CAGR of 6.24% over the forecasting years of 2021 to 2028.


Report scope can be customized per your requirements. Request For Customization

The market in this region is formed by the countries of:

•           China

•           Japan

•           India

•           South Korea

•           Australia & New Zealand

•           ASEAN countries

•           Rest of APAC countries

In a 2017 study, it was found that, around 112.4 million people in China reported suffering from headache disorders in 1990. This number rose to 482.7 million individuals in 2017. According to another study published in the succeeding years, 9.1% of adults in the country had migraine. Notably, people between the ages of 40 and 49 years showed the highest prevalence of migraine. Botulinum toxin is effective in reducing the frequency of headaches and their severity in patients with chronic migraine. Thus, owing to the high rate of prevalence of migraine among Chinese people, the demand for botulinum toxin in the country is expected to increase. 

In 2017, the Journal of Headache and Pain put forth that, the prevalence rate of migraine in Japan falls in the range of approx. 8% to 14%. The number of people suffering from headache or migraine has been rising every year. As per another article, around 59.4% to 71.8% of the people in the nation, who were affected by migraine, had never consulted a doctor for this condition. Migraine also poses an economic burden on the country. It was observed that the productivity of nearly 20% to 30% of people suffering from migraine had declined significantly, and most of the people affected by the condition are unable to go to work. The Japanese are known for their hardworking nature, and thus, the decline in productivity has been instrumental in raising the demand for botulinum toxin in the country. The substance helps control the frequency of headaches associated with chronic migraine. Hence, the growing demand for botulinum toxin is expected to benefit the Japanese botulinum toxin market in the future. 

Evolus Inc. is a renowned player in the beauty & aesthetic products market. The company’s primary market comprises medical products purchased by physicians and other related end-users. These products are then sold to consumers or are used in procedures for aesthetic procedures. The manufacturing of its product, Jeuveau, which is a proprietary 900-kDa purified botulinum toxin type, has been outsourced to Daewoong Pharmaceuticals Co. Ltd. With an experience spanning over 70 years in pharmaceutical manufacturing, Daewoong is one of the largest pharmaceutical companies in South Korea. In fact, the company constructed a facility in South Korea to manufacture Jeuveau.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. ASIA-PACIFIC BOTULINUM TOXIN MARKET – SUMMARY       

2. INDUSTRY OUTLOOK  

2.1. KEY INSIGHTS      

2.1.1. SURGE IN DISPOSABLE INCOME         

2.1.2. GROWING NUMBER OF MEN OPTING FOR COSMETIC TREATMENT   

2.1.3. DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE    

2.2. IMPACT OF COVID-19 ON THE BOTULINUM TOXIN INDUSTRY

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS    

2.3.2. THREAT OF SUBSTITUTE

2.3.3. BARGAINING POWER OF SUPPLIERS

2.3.4. BARGAINING POWER OF BUYERS      

2.3.5. THREAT OF COMPETITIVE RIVALRY  

2.4. MARKET ATTRACTIVENESS MATRIX

2.5. VENDOR SCORECARD 

2.6. KEY MARKET STRATEGIES     

2.6.1. NEW PRODUCT LAUNCHES      

2.7. MARKET DRIVERS         

2.7.1. INCREASING DEMAND FOR AESTHETIC PROCEDURES 

2.7.2. EXPANSION OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS     

2.8. MARKET RESTRAINTS  

2.8.1. ADVERSE EFFECTS ASSOCIATED WITH BOTULINUM TOXIN     

2.8.2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES   

2.8.3. LACK OF INTERCHANGEABILITY BETWEEN BOTULINUM TOXIN PRODUCTS

2.9. MARKET OPPORTUNITIES       

2.9.1. INCREASING AGING POPULATION      

2.9.2. RISE IN MEDICAL TOURISM       

3. ASIA-PACIFIC BOTULINUM TOXIN MARKET – BY TYPE

3.1. TYPE A       

3.2. TYPE B       

4. ASIA-PACIFIC BOTULINUM TOXIN MARKET – BY APPLICATION       

4.1. COSMETIC APPLICATIONS      

4.1.1. GLABELLAR LINES

4.1.2. LATERAL CANTHAL LINES (CROW’S FEET)  

4.1.3. FOREHEAD LINES 

4.1.4. OTHER COSMETIC APPLICATIONS     

4.2. NON-COSMETIC APPLICATIONS        

4.2.1. DYSTONIA   

4.2.2. CHRONIC MIGRAINE        

4.2.3. OPHTHALMOLOGIC DISORDERS         

4.2.4. OTHER NON-COSMETIC APPLICATIONS       

5. ASIA-PACIFIC BOTULINUM TOXIN MARKET – BY END-USER

5.1. HOSPITALS           

5.2. CLINICS AND OTHERS  

6. ASIA-PACIFIC BOTULINUM TOXIN MARKET – REGIONAL OUTLOOK                       

6.1. COUNTRY ANALYSIS    

6.1.1. CHINA

6.1.2. JAPAN           

6.1.3. INDIA 

6.1.4. SOUTH KOREA       

6.1.5. ASEAN COUNTRIES         

6.1.6. AUSTRALIA & NEW ZEALAND   

6.1.7. REST OF ASIA-PACIFIC   

7. COMPETITIVE LANDSCAPE 

7.1. ABBVIE INC           

7.2. EVOLUS INC

7.3. GALDERMA PHARMA SA (ACQUIRED BY EQT)      

7.4. HUGEL INC

7.5. IPSEN PHARMA   

7.6. MERZ PHARMA   

7.7. MEDYTOX INC

7.8. REVANCE THERAPEUTICS INC

7.9. US WORLDMEDS LLC    

8. METHODOLOGY & SCOPE    

8.1. RESEARCH SCOPE & DELIVERABLES        

8.2. SOURCES OF DATA       

8.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2: MARKET ATTRACTIVENESS MATRIX

TABLE 3: VENDOR SCORECARD

TABLE 4: LIST OF NEW PRODUCT LAUNCHES

TABLE 5: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 6: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 7: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 8: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 9: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 10: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 11: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY TYPE, 2020 & 2028 (IN %)

FIGURE 3: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY TYPE A, 2021-2028 (IN $ MILLION)

FIGURE 4: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY TYPE B, 2021-2028 (IN $ MILLION)

FIGURE 5: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 6: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 7: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY GLABELLAR LINES, 2021-2028 (IN $ MILLION)

FIGURE 8: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY LATERAL CANTHAL LINES (CROW’S FEET), 2021-2028 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2021-2028 (IN $ MILLION)

FIGURE 10: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY OTHER COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 11: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY DYSTONIA, 2021-2028 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2021-2028 (IN $ MILLION)

FIGURE 14: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 15: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY OTHER NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY END-USER, 2020 & 2028 (IN %)

FIGURE 17: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 18: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY CLINICS AND OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 19: ASIA-PACIFIC BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 20: CHINA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 21: JAPAN BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 22: INDIA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 23: SOUTH KOREA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 24: ASEAN COUNTRIES BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 25: AUSTRALIA & NEW ZEALAND BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 26: REST OF ASIA-PACIFIC BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;